karppaus.infon arkistoitu foorumi

The Future:"Virta is an online specialty medical clinic that reverses type 2 diabetes safely and sustainably without medications or surgery"

A brand new company called Virta Health launched this week with a bold vision to reverse type 2 diabetes without medications or surgery. The Virta model relies on “nutritional ketosis” (learn more below) driven by carbohydrate restriction – less than 30 grams of carbs per day, paired with a diet high in fat and moderate in protein. Virta calls itself an “online specialty medical clinic” because participants get access to a health coach and physician, online peer support, and ongoing information and feedback on their health.

In ten weeks, the average participant’s A1c dropped by 1% from an average starting A1c of 7.6%. By the end of the study, over half of the participants had an A1c less than 6.5%, the cutoff generally used to define type 2 diabetes.
75% of participants lost at least 5% of their body weight, and the average weight loss was about 7% – for example, a 200-pound person losing 14 pounds. In preliminary six-month data posted on the company’s website, average weight loss has increased to 12%.
More than half of participants in the study reduced or eliminated their use of at least one diabetes medication.
An impressive 87% of those using insulin either decreased their dose or eliminated their use of insulin altogether.
91% of those enrolled in the study completed it, and participants reported the same level of hunger at the study start and after 10 weeks. That indicates the low-carb, high-fat approach was sustainable for most participants and didn’t require starvation. Virta personalizes the food plan and is not focused on counting calories.
Some participants in the study were newly diagnosed, while others had longstanding diabetes. The 262 study participants had an average age of 54 years.
Virta may be best for those who have flexibility on what they will eat – not everyone will want to eat less than 30 grams of carbs per day, though many Virta users have been surprised at how filling the low-carb approach is.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419. doi:10.1007/s00125-004-1427-2.

Fujimoto WY. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. The American Journal of Medicine. 2000;108 Suppl 6a:9S–14S.

Hill NR, Levy JC, Matthews DR. Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2. Diabetes Care. 2013;36(8):2324-2330. doi:10.2337/dc12-0607.

Volek JS, Phinney SD, Forsythe CE, et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009;44(4):297-309. doi:10.1007/s11745-008-3274-2.

Saslow LR, Kim S, Daubenmier JJ, et al. A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes. PLoS ONE. 2014;9(4):e91027. doi:10.1371/journal.pone.0091027.

Dashti HM, Mathew TC, Hussein T, et al. Long-term effects of a ketogenic diet in obese patients. Exp Clin Cardiol. 2004;9(3):200-205. http://www.ncbi.nlm.nih.gov/pubmed/19641727.

Shimazu T, Hirschey MD, Newman J, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339(6116):211-214. doi:10.1126/science.1227166.

Cotter DG, Schugar RC, Crawford PA. Ketone body metabolism and cardiovascular disease. Am J Physiol Heart Circ Physiol. 2013;304(8):H1060-H1076. doi:10.1152/ajpheart.00646.2012.

Edwards C, Canfield J, Copes N, Rehan M, Lipps D, Bradshaw PC. D-beta-hydroxybutyrate extends lifespan in C. elegans. Aging (Albany NY). 2014;6(8):621-644.

Newman JC, Verdin E. β-hydroxybutyrate: much more than a metabolite. Diabetes Res Clin Pract. 2014;106(2):173-181. doi:10.1016/j.diabres.2014.08.009.

Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005;142(6):403-411. http://www.ncbi.nlm.nih.gov/pubmed/15767618.

Gumbiner B, Wendel JA, McDermott MP. Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non-insulin-dependent diabetes mellitus. American Journal of Clinical Nutrition. 1996;63(1):110-115.

Laibson D. Golden Eggs and Hyperbolic Discounting. The Quarterly Journal of Economics. 1997;112(2):443-478. doi:10.1162/003355397555253.

Loewenstein G, Prelec D. Anomalies in Intertemporal Choice: Evidence and an Interpretation. The Quarterly Journal of Economics. 1992;107(2):573-597. doi:10.2307/2118482.

Shapiro JM. Is there a daily discount rate? Evidence from the food stamp nutrition cycle. Journal of Public Economics. 2005;89(2-3):303-325. doi:10.1016/j.jpubeco.2004.05.003.

Richards TJ, Hamilton SF. Obesity and Hyperbolic Discounting: An Experimental Analysis. Journal of Agricultural and Resource Economics. 2012;37(2):181-198.

Cutler DM, Glaeser EL, Shapiro JM. Why Have Americans Become More Obese? Journal of Economic Perspectives. 2003;17(3):93-118. doi:10.1257/089533003769204371.

Ikeda S, Kang M-I, Ohtake F. Hyperbolic discounting, the sign effect, and the body mass index. Journal of Health Economics. 2010;29(2):268-284. doi:10.1016/j.jhealeco.2010.01.002.

Chou S-Y, Grossman M, Saffer H. An economic analysis of adult obesity: results from the Behavioral Risk Factor Surveillance System. Journal of Health Economics. 2004;23(3):565-587. doi:10.1016/j.jhealeco.2003.10.003.

Burke LE, Wang J, Sevick MA. Self-Monitoring in Weight Loss: A Systematic Review of the Literature. Journal of the American Dietetic Association. 2011;111(1):92-102. doi:10.1016/j.jada.2010.10.008.

Dashti HM, Mathew TC, Khadada M, et al. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem. 2007;302(1-2):249-256. doi:10.1007/s11010-007-9448-z.

Yusuf S, Bosch J, Dagenais G, et al. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. April 2016. doi:10.1056/NEJMoa1600176.

Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertens. 1994;7(7 Pt 2):7S–12S.

Westman EC, Yancy WS, Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond). 2008;5:36. doi:10.1186/1743-7075-5-36.

Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359(3):229-241. doi:10.1056/NEJMoa0708681.

Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013;97(3):505-516. doi:10.3945/ajcn.112.042457.

Hu T, Mills KT, Yao L, et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. American Journal of Epidemiology. 2012;176 Suppl 7:S44-S54. doi:10.1093/aje/kws264.

Bazzano LA, Hu T, Reynolds K, et al. Effects of low-carbohydrate and low-fat diets: a randomized trial. Ann Intern Med. 2014;161(5):309-318. doi:10.7326/M14-0180.

Ballard KD, Quann EE, Kupchak BR, et al. Dietary carbohydrate restriction improves insulin sensitivity, blood pressure, microvascular function, and cellular adhesion markers in individuals taking statins. Nutr Res. 2013;33(11):905-912. doi:10.1016/j.nutres.2013.07.022.

Bistrian BR, Blackburn GL, Flatt JP, Sizer J, Scrimshaw NS, Sherman M. Nitrogen metabolism and insulin requirements in obese diabetic adults on a protein-sparing modified fast. Diabetes. 1976;25(6):494-504.

Gannon MC, Nuttall FQ. Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes. 2004;53(9):2375-2382.

Robertson MD, Henderson RA, Vist GE, Rumsey RDE. Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism. American Journal of Clinical Nutrition. 2002;75(3):505-510.

Cahill GF Jr., Aoki TT. Alternate Fuel Utilization by Brain. In: Cerebral Metabolism and Neural Function. Baltimore; 1980:234-242.

Badman MK, Kennedy AR, Adams AC, Pissios P, Maratos-Flier E. A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss. Am J Physiol Endocrinol Metab. 2009;297(5):E1197-E1204. doi:10.1152/ajpendo.00357.2009.

Cotter DG, Ercal B, d'Avignon DA, Dietzen DJ, Crawford PA. Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice. Am J Physiol Endocrinol Metab. 2014;307(2):E176-E185. doi:10.1152/ajpendo.00087.2014.

Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607. doi:10.1016/0899-9007(97)90878-9.

Cotter DG, Ercal B, d'Avignon DA, Dietzen DJ, Crawford PA. Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth. J Biol Chem. 2013;288(27):19739-19749. doi:10.1074/jbc.M113.454868.

Crawford PA, Crowley JR, Sambandam N, et al. Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc Natl Acad Sci USA. 2009;106(27):11276-11281. doi:10.1073/pnas.0902366106.

Gibson CL, Murphy AN, Murphy SP. Stroke outcome in the ketogenic state - a systematic review of the animal data. J Neurochem. 2012;123:52-57. doi:10.1111/j.1471-4159.2012.07943.x.
Wilder RM. The effect of ketonemia on the course of epilepsy. Mayo Clinic Bulletin. 1921;2:307-308.

Guelpa G, Marie A. La lutte contre l’epilepsie par la desintoxication et par la reeducation alimentaire [The fight against epilepsy by detoxification and by food reduction]. Rev Ther Med Chir Paris. 1911;78:8-13. doi:10.1111/j.1528-1157.1911.tb03003.x.

DeToledo JC, Lowe MR. Epilepsy, demonic possessions, and fasting: another look at translations of Mark 9:16. Epilepsy & Behavior. 2003;4(3):338-339. doi:10.1016/S1525-5050(03)00038-6.

Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7(6):500-506. doi:10.1016/S1474-4422(08)70092-9.

Payne NE, Cross JH, Sander JW, Sisodiya SM. The ketogenic and related diets in adolescents and adults--a review. Epilepsia. 2011;52(11):1941-1948. doi:10.1111/j.1528-1167.2011.03287.x.

Hemingway C, Freeman JM, Pillas DJ, Pyzik PL. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. PEDIATRICS. 2001;108(4):898-905.

Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. PEDIATRICS. 1998;102(6):1358-1363.

Thiele EA. Assessing the efficacy of antiepileptic treatments: the ketogenic diet. Epilepsia. 2003;44 Suppl 7:26-29.

Zhao Z, Lange DJ, Voustianiouk A, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29. doi:10.1186/1471-2202-7-29.

Abdelwahab MG, Fenton KE, Preul MC, et al. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS ONE. 2012;7(5):e36197. doi:10.1371/journal.pone.0036197.

Gano LB, Patel M, Rho JM. Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res. 2014;55(11):2211-2228. doi:10.1194/jlr.R048975.

Barañano KW, Hartman AL. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr Treat Options Neurol. 2008;10(6):410-419.

Kwiterovich PO, Vining EPG, Pyzik P, Skolasky R, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA. 2003;290(7):912-920. doi:10.1001/jama.290.7.912.

Forsythe CE, Phinney SD, Fernandez ML, et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008;43(1):65-77. doi:10.1007/s11745-007-3132-7.

DiNicolantonio JJ. The cardiometabolic consequences of replacing saturated fats with carbohydrates or Ω-6 polyunsaturated fats: Do the dietary guidelines have it wrong? Open Heart. 2014;1(1):e000032-e000032. doi:10.1136/openhrt-2013-000032.

Kapetanakis M, Liuba P, Odermarsky M, Lundgren J, Hallböök T. Effects of ketogenic diet on vascular function. Eur J Paediatr Neurol. 2014;18(4):489-494. doi:10.1016/j.ejpn.2014.03.006.

Gardner CD, Kiazand A, Alhassan S, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007;297(9):969-977. doi:10.1001/jama.297.9.969.

Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293(1):43-53. doi:10.1001/jama.293.1.43.

Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003;348(21):2082-2090. doi:10.1056/NEJMoa022207.

Yancy WS, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004;140(10):769-777.

Hays JH, DiSabatino A, Gorman RT, Vincent S, Stillabower ME. Effect of a high saturated fat and no-starch diet on serum lipid subfractions in patients with documented atherosclerotic cardiovascular disease. Mayo Clin Proc. 2003;78(11):1331-1336. doi:10.4065/78.11.1331.

Krebs NF, Gao D, Gralla J, Collins JS, Johnson SL. Efficacy and safety of a high protein, low carbohydrate diet for weight loss in severely obese adolescents. J Pediatr. 2010;157(2):252-258. doi:10.1016/j.jpeds.2010.02.010.

Chiu S, Bergeron N, Williams PT, Bray GA, Sutherland B, Krauss RM. Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial. American Journal of Clinical Nutrition. 2016;103(2):341-347. doi:10.3945/ajcn.115.123281.

Sacks FM, Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. The American Journal of Medicine. 2002;113(9):13-24. doi:10.1016/S0002-9343(01)00987-1.

Nordmann AJ, Nordmann A, Briel M, et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166(3):285-293. doi:10.1001/archinte.166.3.285.

Westman EC, Feinman RD, Mavropoulos JC, et al. Low-carbohydrate nutrition and metabolism. American Journal of Clinical Nutrition. 2007;86(2):276-284.

Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91(3):535-546. doi:10.3945/ajcn.2009.27725.

Paoli A. Ketogenic diet for obesity: friend or foe? Int J Environ Res Public Health. 2014;11(2):2092-2107. doi:10.3390/ijerph110202092.

Noakes T, Volek JS, Phinney SD. Low-carbohydrate diets for athletes: what evidence? Br J Sports Med. 2014;48(14):1077-1078. doi:10.1136/bjsports-2014-093824.

Hashimoto Y, Fukuda T, Oyabu C, et al. Impact of low-carbohydrate diet on body composition: meta-analysis of randomized controlled studies. Obesity Reviews. 2016;17(6):499-509. doi:10.1111/obr.12405.

MS SHD, PhD AM, PhD BC, et al. Improvement in Atherogenic Dyslipidemia at 70 Days Following a Reduced Carbohydrate Intervention for Treatment of Type 2 Diabetes. J Clin Lipidol. 2016;10(3):665. doi:10.1016/j.jacl.2016.03.030.

Gilks JL, Orr JB. The nutritional condition of the East African Native. The Lancet. 1927;209(5402):560-562. doi:10.1016/S0140-6736(00)75124-5.

Cassidy CM. Nutrition and Health in Agriculturalists and Hunter-Gatherers: A Case Study of Two Populations. In: Jerome NW, ed. Nutritional Anthropology. Pleasantville, NY; 1980:117-145.

Banting W. Letter on Corpulence, Addressed to the Public. 1869. Vol 1. 1993:153-163.

Hussain TA, Mathew TC, Dashti AA, Asfar S, Al-Zaid N, Dashti HM. Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes. Nutrition. 2012;28(10):1016-1021. doi:10.1016/j.nut.2012.01.016.

Feinman RD, Pogozelski WK, Astrup A, et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015;31(1):1-13. doi:10.1016/j.nut.2014.06.011.

Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256(20):2835-2838.

Forsythe CE, Phinney SD, Feinman RD, et al. Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids. 2010;45(10):947-962. doi:10.1007/s11745-010-3467-3.

Volk BM, Kunces LJ, Freidenreich DJ, et al. Effects of step-wise increases in dietary carbohydrate on circulating saturated Fatty acids and palmitoleic Acid in adults with metabolic syndrome. PLoS ONE. 2014;9(11):e113605. doi:10.1371/journal.pone.0113605.

Wang L, Folsom AR, Zheng Z-J, Pankow JS, Eckfeldt JH, ARIC Study Investigators. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Clinical Nutrition. 2003;78(1):91-98.

Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metab Clin Exp. 2014;63(7):895-902. doi:10.1016/j.metabol.2014.04.003.

Wang Y, Viscarra J, Kim S-J, Sul HS. Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Biol. 2015;16(11):678-689. doi:10.1038/nrm4074.

Sanders FWB, Griffin JL. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev Camb Philos Soc. 2016;91(2):452-468. doi:10.1111/brv.12178.

Ramsden CE, Zamora D, Majchrzak-Hong S, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ. 2016;353:i1246. doi:10.1136/bmj.i1246.

Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707. doi:10.1136/bmj.e8707.

Ravnskov U, Diamond DM, Hama R, et al. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open. 2016;6(6):e010401. doi:10.1136/bmjopen-2015-010401.

Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids. 2010;45(10):893-905. doi:10.1007/s11745-010-3393-4.

Yakoob MY, Shi P, Willett WC, et al. Circulating Biomarkers of Dairy Fat and Risk of Incident Diabetes Mellitus Among US Men and Women in Two Large Prospective Cohorts. Circulation. March 2016. doi:10.1161/CIRCULATIONAHA.115.018410.

Fretts AM, Mozaffarian D, Siscovick DS, et al. Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain Length. J Nutr. 2016;146(2):298-305. doi:10.3945/jn.115.222117.

Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398-406. doi:10.7326/M13-1788.

Pokrywka GS. Guest Editorial: Worsening Lipoproteins on a Low-Carb Diet. LipidSpin. 2016;14(2):10-13.

Lamarche B, Lemieux I, Després JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab. 1999;25(3):199-211.

Lecerf J-M, de Lorgeril M. Dietary cholesterol: from physiology to cardiovascular risk. Br J Nutr. 2011;106(1):6-14. doi:10.1017/S0007114511000237.

Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):655-666. doi:10.1001/jama.295.6.655.

Phinney SD, Tang AB, Waggoner CR, Tezanos-Pinto RG, Davis PA. The transient hypercholesterolemia of major weight loss. American Journal of Clinical Nutrition. 1991;53(6):1404-1410.

Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207. doi:10.1056/NEJMoa0807646.

Awan Z, Genest J. Inflammation modulation and cardiovascular disease prevention. Eur J Prev Cardiol. 2015;22(6):719-733. doi:10.1177/2047487314529350.

van Bussel BCT, Henry RMA, Ferreira I, et al. A healthy diet is associated with less endothelial dysfunction and less low-grade inflammation over a 7-year period in adults at risk of cardiovascular disease. J Nutr. 2015;145(3):532-540. doi:10.3945/jn.114.201236.

Pacy PJ, Price GM, Halliday D, Quevedo MR, Millward DJ. Nitrogen homeostasis in man: the diurnal responses of protein synthesis and degradation and amino acid oxidation to diets with increasing protein intakes. Clin Sci. 1994;86(1):103-116.

Tarnopolsky MA, Atkinson SA, MacDougall JD, Chesley A, Phillips S, Schwarcz HP. Evaluation of protein requirements for trained strength athletes. Journal of Applied Physiology. 1992;73(5):1986-1995.

Phillips SM, Moore DR, Tang JE. A critical examination of dietary protein requirements, benefits, and excesses in athletes. Int J Sport Nutr Exerc Metab. 2007;17 Suppl:S58-S76.

American Diabetes Association, Bantle JP, Wylie-Rosett J, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31 Suppl 1:S61-S78. doi:10.2337/dc08-S061.

Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370(16):1514-1523. doi:10.1056/NEJMoa1310799.

Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: Insights from Yesterday, Today, and Future Trends. Popul Health Manag. April 2016. doi:10.1089/pop.2015.0181.

Evert AB, Boucher JL, Cypress M, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013;36(11):3821-3842. doi:10.2337/dc13-2042.

Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. The Lancet. 1997;350(9080):757-764. doi:10.1016/S0140-6736(97)05381-6.

DeHaven J, Sherwin R, Hendler R, Felig P. Nitrogen and sodium balance and sympathetic-nervous-system activity in obese subjects treated with a low-calorie protein or mixed diet. N Engl J Med. 1980;302(9):477-482. doi:10.1056/NEJM198002283020901.

Mente A, O'Donnell MJ, Rangarajan S, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371(7):601-611. doi:10.1056/NEJMoa1311989.

O'Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371(7):612-623. doi:10.1056/NEJMoa1311889.

Kearns CE, Schmidt LA, Glantz SA. Sugar Industry and Coronary Heart Disease ResearchA Historical Analysis of Internal Industry Documents. JAMA Intern Med. 2016;176(11):1680-1685. doi:10.1001/jamainternmed.2016.5394

The launch of Virta Health – Reversing T2 diabetes in 100M people with keto, tech and great people: https://www.dietdoctor.com/launch-virta ... ion-people …

Talouselämä: Oma kokemus kannusti teknologia-miljonääria – haluaa uudella yrityksellä vähentää diabeetikkojen määrää



Karppausta saati ketokarppausta jutussa ei tietenkään mainita. Kiellettyjä sanoja (kuten karppaus, vähähiilihydraattinen ruokavaliio, LCHF) ei "sananvapauden kärkimaassa" ilmeisesti saa mainita, ei ainakaan missään positiivisessa kontekstissa. Kansa ei missään tapauksessa saa tietää, että diabetes voidaan ehkäistä ja puhkeamaan päässyt diabetes saada remissioon rajoittamalla ruokavaliossa verensokeria ja inskaa nostavia makroja eli hiilihydraatteja ja proteiineja, erityisesti ensinmainittuja.

När diabetiker blir äldre och skröpligare kan aptiten minska, och blodsockret går ner. Diabetesmedicineringen måste då följa med ner. Speciellt om diabetikern äter LCHF. Då mår hen bättre och risken för lågt blodsocker minskar eller försvinner. Många kan bli av med diabetesmedicineringen helt och hållet.
Det är vanligt att personal och läkare inte tänker på detta, då drabbas patienten av vårdskada. Om inte varken patient eller personal tänker på det är det viktigt att anhöriga påminner om det.

But suddenly diabetes has emerged as the biggest killer of South African women and the second biggest killer overall, according to 2015 death statistics released recently by Statistics South Africa.

Seven years before this, diabetes was not even in the Top 10 killers.

LN kommentoi vielä: Valtavirran lääketiedettä suosivat eivät halua, että diabeetikot parantuvat. Tämä on päivänselvää kun lukee JJ:n vastaukset. Myöskään Duodeciminin Käypä hoitosuosituksissa remissiota ei edes mainita mahdollisuutena. Suurin ongelma ja tärkein syy tähän mielivaltaan on se, että diabeetikkojen tulisi syödä virallisten ruokasuositusten mukaan 45-60% hiilihydraatteja. Tällaisella hiilihydraattimäärällä veren sokeriarvoja ei koskaan saada terveyttä edistävälle tasolle eli sopivan alhaisiksi, vaikka kuinka paljon insuliinia annostellaan. Mutta liitännäissairauksien vaikutukset on taattu. Lista on pitkä ja potilas kärsii. Diabeetikon tärkein elämäntapamuutos on siirtyä tiukkaan vähähiilihydraattiseen ruokavalioon (VHH, LCHF). Se ei maksa mitään ja positiiviset vaikutukset ovat lähes välittömät.

Tri Kraft kuoli hiljattain 95 vuoden korkeassa iässä.
Häntä haastatellaan vahvalla aksentilla parissa videossa. Videoissa on myös englanninkielinen tekstitys, koska vanha mies ei jaksa puhua kovalla äänellä.

Hän siis tuli siihen tulokseen, että diabetes diagnosoidaan vuosia liian myöhään. Hän kehitti insuliinirasitustestin, joka osoittaa diabeteksen kauan ennenkuin verensokeri alkaa kohota. Tietenkin hänet vaiettiin kuoliaaksi.

Sokerilla on upea väestönkasvua rajoittava vaikutus....

The number of people in the UK with type 2 diabetes has trebled from 700,000 to about 2.8m over the last 20 years, Cardiff university has found.

Type 2 diabetes can be reversed in just four months by cutting calories, exercising and keeping glucose under control, a trial has shown.
Although the condition is considered to be chronic, requiring a lifetime of medication, Canadian researchers proved it was possible to restore insulin production for 40 per cent of patients.
The treatment plan involved creating a personalised exercise regime for each trial participant and reducing their calories by between 500 and 750 a day. The participants also met regularly with a nurse and dietician to track progress and continued to take medication and insulin to manage their blood sugar levels